Acquisition momentum Athena Diagnostics is now part of Siemens Healthineers through a 2023 acquisition, signaling access to larger-scale resources and potential collaboration opportunities with a global diagnostics ecosystem.

Neurology testing focus As a leader in genetic testing for neurology, Athena offers a strong entry point for expanding genetic panels and companion diagnostics related to ataxia and other neurodegenerative conditions.

Growing test portfolio With over 300 diagnostic tests and a substantial revenue footprint, there is opportunity to upsell additional molecular, genetic, and personalized medicine services to existing clinicians and health systems.

Clinical data potential Utilize Athena’s HIPAA-compliant data handling and diverse test results to propose data-enabled services such as analytics, reporting dashboards, and integration with electronic health records for streamlined workflows.

Strategic partnerships Given Quest Diagnostics’ ownership of Athena Diagnostics and the recent lab service expansion, there are openings for co-branded testing programs, referral networks, and consolidated payer strategy to broaden market reach.